期刊文献+

VEGF、CD44_(V6)、MMP联合检测对良、恶性胸水的鉴别意义 被引量:6

The Differential diagnostic meaning of VEGF, CD44_(V6), MMP combined test in pleural effusions
下载PDF
导出
摘要 目的:探讨CD44V6、VEGF、MMP2、MMP9单项和联合检测在良恶性胸腔积液性质鉴别诊断中的价值。方法:选取60名胸腔积液患者,30例为恶性胸腔积液,30例为良性胸腔积液。抽取胸腔积液后,采用ELISA方法分别进行VEGF、CD44V6、MMP2、MMP9检测。结果:在单项检测指标中,VEGF的诊断效能最好,其诊断分界点为181.1pg/ml,敏感性为90.0%,特异性为86.7%。联合检测中,以(VEGF+CD44V6)和(VEGF+MMP2)的诊断效能较好。VEGF+CD44V6联合检测的敏感性为83.3%,特异性为90.0%。VEGF+MMP2联合检测的敏感性为80.0%,特异性93.3%。结论:恶性胸腔积液中的VEGF、CD44V6、MMP2、MMP9水平明显高于良性胸腔积液。单项检测中VEGF有较高的敏感性和特异性;联合检测以VEGF+CD44V6和VEGF+MMP2的敏感性和特异性为最高。 Objective:To observe the diagnostic value of VEGF, CD44V6, MMP2, MMP9 and their combined examination in distinguishing malignant pleural effusion from benign one. Methods:Sixty patients with pleural effusions were observed, thirty ofthemsufferred from malignant pleura1 effusion andthirtyof them sufferred from benign one. The expression of CD44V6, VEGF, MMP2, MMP9 in the pleural effusion were tested with ELISA technique. Results : As single-item detection, the diagnosetic value of VEGF is the best, the cutoff of VEGF was 181.1pg/ml, the sensitivity of VEGF examination was 90.0%, the specificity was 86.7%. The sensitivity and the specificity of combined examination VEGF+CD44V6 and VEGF+MMP2 were the best, the sensitivity of VEGF+CD44V6 was 83.3%, the specificity was 90.0%. The sensitivity of VEGF+MMP2 was 80.0%, the specificity was 93.3%. Conclusion:The level of VEGF, CD44V6, MMP2, MMP9 in malignant pleural effusion is clearly higher than that in benign pleura1 one. VEGF has higher sensitivity and specificity. As combined examination, VEGF+CD44V6 and VEGF+MMP2 have higher sensitivity and specificity.
出处 《温州医学院学报》 CAS 2006年第4期350-353,共4页 Journal of Wenzhou Medical College
基金 舟山市科技局科研基金资助项目(05579)。
关键词 胸腔积液 CD44V6 VEGF MMP 鉴别诊断 联合检测 pleural effusion CD44V6 matrix metalloproteinase differential diagnosis combined examination
  • 相关文献

参考文献12

  • 1Braunschweig R, Yan E Guilleret I, et al. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination[J]. Diagn Cytopathol, 2001, 24(3): 174-180.
  • 2Motherby H, Nadjari B, Friegel P, et al. Diagnostic accuracy of effusion cytology[J]. Diagn Cytopathol, 1999,20(6): 350-357.
  • 3Zeimet AG, Widschwendter M, Uhl-Steidl M, et al. High serum levels of soluble CD44 variant isoform V5 are associated with favorable clinical outcome in ovarian cancer[J]. Br J Cancer, 1997,76(12): 1646-1651.
  • 4Peterson RM, Yu Q, Stamenkovic I, et al. Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites[J]. Am J Pathol,2000,156(6):2159-2167.
  • 5Weidner N.Introtumor microvessel density as a prognostic factor in cancer[J].Am J Pathol,1995,147(1):9-19.
  • 6Mori A,Arii S,Furutani M,et al. Soluble Flt- 1 gene therapy for peritoneal metastases using HVJ-cationic liposomes[J]. Gene Therapy, 2000,7(7): 1027-1033.
  • 7Zebrowski B K, Liu W, Ramirez K, et al. Markedly elevated levels of vascular endothelial growth factor in malignant ascites[J]. Ann Sury Oncol, 1999,6(3):373-378.
  • 8Nakopoulou L, Tsirmpa I, Alexandrou P, et al. MMP2 protein in invasive breast cancer and the impact of MMP2/TIMP-2 phenotype on overall survival[J]. Breast Cancer Res Treat,2003, 77(22): 145-155.
  • 9Ohashi K, Nemoto T, Nakamura K, ET AL. Increased expression of matrix metalloproteinase7 and 9 and membrane type Ⅰ-matrix metalloproteinase in esophageal squamous cell carcinomas[J].Cancer, 2000, 88(10):2201-2209.
  • 10Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis[J]. Nature Cell Biol, 2000, 2(10):734-744.

同被引文献48

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部